$0.00010
0.0000999900.00%
At close: -
$0.000001
-0.000099-99.00%
After Hours: Oct 9, 6:55 PM EDT
Comments
Loading...
Latest news for Aridis Pharmaceuticals (OTC:ARDS) Stock
Aridis Pharmaceuticals Stock (OTC: ARDS)
Categories: All
Monday, November 06, 2023
Friday, November 03, 2023
Friday, October 20, 2023
Tuesday, July 18, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Why Are Aridis Pharmaceuticals Shares Moving Higher Today?
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
- Aridis Pharmaceuticals shares are trading hig...
Monday, July 17, 2023
Friday, July 14, 2023
Thursday, July 13, 2023
Wednesday, July 12, 2023
Tuesday, June 20, 2023
Thursday, June 08, 2023
Thursday, June 01, 2023
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Wednesday, May 31, 2023
- Why Aridis Pharmaceuticals Shares Are Soaring Today
- Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss Views
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Aridis Pharmaceuticals shares are trading hig...
- Aridis Receives Agreement From FDA On A Singl...
Thursday, May 25, 2023
Tuesday, May 23, 2023
Wednesday, April 26, 2023
Monday, April 10, 2023
Thursday, April 06, 2023
Monday, April 03, 2023
Friday, March 31, 2023
Wednesday, March 29, 2023
- AstraZeneca Axes Pneumonia Drug Pact With Aridis
- Aridis Pharmaceuticals Said On March 20, Got Written Notice From Medimmune That It Has Terminated License Agreement Dated As Of July 12, 2021 Effective March 30; As Result Of Termination Notice, On-going Ar-320-003 Phase 3 Clinical Study Must Be Put On Hold
Tuesday, March 14, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Stocks That Hit 52-Week Lows On Tuesday
- Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Why Aridis Pharmaceuticals Shares Are Diving
- Aridis Pharmaceuticals shares are trading low...
- Aridis Pharmaceuticals Announces $2.28M Offer...